Vildagliptin Prices Fall By Over 70% In India Post Patent Expiry

Novartis Sells Vildagliptin Brand To USV, Cipla Explores Talks

 
• By Vibha Ravi
Wrestlers
Gliptins Price War Set To Intensify • Source: Shutterstock

More from Business

More from Scrip